India
· Delayed Price · Currency is INR Suven Life Sciences Statistics
Total Valuation
BOM:530239 has a market cap or net worth of INR 51.39 billion. The enterprise value is 50.79 billion.
| Market Cap | 51.39B |
| Enterprise Value | 50.79B |
Important Dates
The last earnings date was Wednesday, May 28, 2025.
| Earnings Date | May 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:530239 has 218.07 million shares outstanding. The number of shares has increased by 0.22% in one year.
| Current Share Class | 218.07M |
| Shares Outstanding | 218.07M |
| Shares Change (YoY) | +0.22% |
| Shares Change (QoQ) | -0.45% |
| Owned by Insiders (%) | 2.08% |
| Owned by Institutions (%) | 6.91% |
| Float | 61.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 678.49 |
| PB Ratio | 26.67 |
| P/TBV Ratio | 26.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -35.43 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,065.49 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -37.09% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 537,163 |
| Profits Per Employee | -10.17M |
| Employee Count | 141 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -10.02M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +124.92% in the last 52 weeks. The beta is 0.82, so BOM:530239's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | +124.92% |
| 50-Day Moving Average | 173.86 |
| 200-Day Moving Average | 141.88 |
| Relative Strength Index (RSI) | 59.37 |
| Average Volume (20 Days) | 142,763 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:530239 had revenue of INR 75.74 million and -1.43 billion in losses. Loss per share was -6.58.
| Revenue | 75.74M |
| Gross Profit | 67.50M |
| Operating Income | -1.58B |
| Pretax Income | -1.44B |
| Net Income | -1.43B |
| EBITDA | -1.52B |
| EBIT | -1.58B |
| Loss Per Share | -6.58 |
Balance Sheet
The company has 1.66 billion in cash and 2.44 million in debt, giving a net cash position of 1.66 billion or 7.62 per share.
| Cash & Cash Equivalents | 1.66B |
| Total Debt | 2.44M |
| Net Cash | 1.66B |
| Net Cash Per Share | 7.62 |
| Equity (Book Value) | 1.93B |
| Book Value Per Share | 8.81 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 89.12% |
| Operating Margin | -2,086.21% |
| Pretax Margin | -1,905.77% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BOM:530239 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.22% |
| Shareholder Yield | n/a |
| Earnings Yield | -2.79% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 23, 2007. It was a forward split with a ratio of 4.
| Last Split Date | Mar 23, 2007 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |